Jonathan Root - Nov 23, 2021 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Signature
Dale Holladay, Attorney in Fact for the Reporting Person
Stock symbol
EFTR
Transactions as of
Nov 23, 2021
Transactions value $
-$413,996
Form type
4
Date filed
11/26/2021, 03:44 PM
Previous filing
Nov 22, 2021
Next filing
Dec 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Sale -$107K -14.4K -0.32% $7.40 4.5M Nov 23, 2021 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$3.41K -461 -0.32% $7.40 144K Nov 23, 2021 Directly owned by AFF X F1, F2
transaction EFTR Common Stock Sale -$260K -35.4K -0.79% $7.36 4.47M Nov 24, 2021 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$8.33K -1.13K -0.79% $7.36 143K Nov 24, 2021 Directly owned by AFF X F1, F2
transaction EFTR Common Stock Sale -$34.1K -4.87K -0.11% $7.01 4.46M Nov 26, 2021 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$1.09K -156 -0.11% $7.01 143K Nov 26, 2021 Directly owned by AFF X F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.33 to $7.63; inclusive for sales on 11/23/21; prices ranging from $7.25 to $7.48, inclusive for sales on 11/24/21; and prices ranging from $6.75 to $7.34, inclusive for sales on 11/26/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4
F2 Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X with additional rights with respect to the Issuer securities, and may be deemed to have sole voting and dispositive power with respect to the shares. The Reporting Person disclaims beneficial ownership of shares held by the USVP X Funds, except to the extent of any proportionate pecuniary interest therein.